MedPath

Post COVID 19 illness and Homoeopathy

Phase 2
Conditions
Health Condition 1: U07-
Registration Number
CTRI/2022/09/045738
Lead Sponsor
Central Council for Research in Homoeopathy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

After more than 4 weeks after a positive test for SARS-CoV-2(RTPCR / Rapid antigen test/ IgM antibodies against SARS-CoV-2) AND

Reports complaints dating back to COVID-19 illness

The cases will be included in 3 parallel study sets:

Repeat testing has been done at least 10 days after the first test and the patient has been identified to be positive for SARS-CoV-2 antigens;

Repeat testing at least 10 days after the first test has been done and the patient has been identified to be negative for SARS-CoV-2 antigens;

No repeat antigen testing has been done

Exclusion Criteria

Oxygen saturation SPO2below 95% in room air;

Pre-existing pulmonary conditions such as bronchial asthma, COPD, etc. ;

Patients on regular bronchodilators, or respiratory medicines through inhaler or nebulizer (self reported treatment history);

Suffering from chronic life-threatening condition(s) requiring repeated hospitalizations / tertiary care treatments such as pre-existing malignancy, chronic renal failure, chronic liver failure, uncontrolled diabetes or uncontrolled Hypertension or any other complaint as per the discretion of the treating physician which may jeopardize patient participation in the study; patients on steroids during last 03 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Days to resolution of symptoms <br/ ><br>Change in symptom severity <br/ ><br>Overall change in patient health <br/ ><br>Development of new symptomsTimepoint: every week for 8 weeks
Secondary Outcome Measures
NameTimeMethod
Compilation of profile of patients seeking homoeopathic treatment for post acute COVID ââ?¬â?? 19 in terms of their disease profile, pre-existing health status and treatment preferences in the recent pastTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath